SARS-CoV-2 is associated with changes in brain structure in UK Biobank
2022/03/07 by Gwenaëlle Douaud, Soojin Lee, Fidel Alfaro‐Almagro +17 · 1 voice · 1,563 citations
Medicine · Neuroscience · Psychology · #Anosmia #Atrophy #Biobank #Bioinformatics #Biology #Cognition #Coronavirus disease 2019 (COVID-19) #Dementia #Disease #Entorhinal cortex #Grey matter #Hippocampus #Internal medicine #Long-Term Effects of COVID-19 #Magnetic resonance imaging #Medicine #Neuroimaging #Neuroinflammation and Neurodegeneration Mechanisms #Neuroscience #Olfactory and Sensory Function Studies #Orbitofrontal cortex #Parahippocampal gyrus #Pathology #Prefrontal cortex #Psychiatry #Psychology #Radiology #Temporal lobe #White matter
paper · pdf · doi:10.1038/s41586-022-04569-5
published in Nature 604(7907), 697-707 (Nature Portfolio)
openalex publication_date 2022/03/07 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01
Abstract
. However, it remains unknown whether the impact of SARS-CoV-2 infection can be detected in milder cases, and whether this can reveal possible mechanisms contributing to brain pathology. Here we investigated brain changes in 785 participants of UK Biobank (aged 51-81 years) who were imaged twice using magnetic resonance imaging, including 401 cases who tested positive for infection with SARS-CoV-2 between their two scans-with 141 days on average separating their diagnosis and the second scan-as well as 384 controls. The availability of pre-infection imaging data reduces the likelihood of pre-existing risk factors being misinterpreted as disease effects. We identified significant longitudinal effects when comparing the two groups, including (1) a greater reduction in grey matter thickness and tissue contrast in the orbitofrontal cortex and parahippocampal gyrus; (2) greater changes in markers of tissue damage in regions that are functionally connected to the primary olfactory cortex; and (3) a greater reduction in global brain size in the SARS-CoV-2 cases. The participants who were infected with SARS-CoV-2 also showed on average a greater cognitive decline between the two time points. Importantly, these imaging and cognitive longitudinal effects were still observed after excluding the 15 patients who had been hospitalised. These mainly limbic brain imaging results may be the in vivo hallmarks of a degenerative spread of the disease through olfactory pathways, of neuroinflammatory events, or of the loss of sensory input due to anosmia. Whether this deleterious effect can be partially reversed, or whether these effects will persist in the long term, remains to be investigated with additional follow-up.
Cited by
- A Case Definition of a New Disease: A Review of the US Working Definition (USG) and 2024 NASEM Definition for Long COVID
- Unveiling the Intricacies of Implicit Motor Learning in Adults Recovered from COVID-19
- Need for awareness and surveillance of long-term post-COVID neurodegenerative disorders. A position paper from the neuroCOVID‐19 task force of the European Academy of Neurology
- Understanding the long-term neurological effects of SARS-CoV-2 infection
- SARS‐CoV‐2 Infection Induces Dopaminergic Neuronal Loss in Midbrain Organoids
- Systemic increase of AMPA receptors associated with cognitive impairment of long COVID
- Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
- Review of organ damage from COVID and Long COVID: a disease with a spectrum of pathology
- SARS-CoV-2 spike protein causes synaptic dysfunction and p-tau and α-synuclein aggregation leading cognitive impairment: The protective role of metformin
- Accelerated brain ageing during the COVID-19 pandemic
- Multimodal imaging suggests potential immune-vascular contributions to altered regional brain perfusion and oxygen metabolism in Post-COVID-19 Syndrome
- Neurocognitive and emotional long-term effects of COVID-19 infections in children and adolescents: results from a clinical survey in Bavaria, Germany
- Persistent Cerebral 18-FDG PET Changes in Patients With Long COVID Presenting With Fatigue and Post Exertional Malaise
- Combination antiviral and anti-inflammatory therapy mitigates persistent neurological deficits in mice post SARS-CoV-2 infection
- COVID-19 Is Airborne AIDS: Provocative Oversimplification, Emerging Science, or Something in Between?
- A public health perspective of SARS-CoV-2 evolution and surveillance strategies in Germany from 2020 to 2023
- Bilingualism predicts executive function resilience after COVID-19 in aging
- COVID-19 related cognitive, structural and functional brain changes among Italian adolescents and young adults: a multimodal longitudinal case-control study
- Altered functional brain connectivity, efficiency, and information flow associated with brain fog after mild to moderate COVID-19 infection
- Plasma proteomic evidence for increased β-amyloid pathology after SARS-CoV-2 infection
- Neurological, psychological, psychosocial complications of long-COVID and their management
- Serotonin reduction in post-acute sequelae of viral infection
- Vaccination reduces central nervous system IL-1β and memory deficits after COVID-19 in mice
- Influences of sex and gender on the associations between risk and protective factors, brain, and behavior
- Long COVID science, research and policy
- Long COVID Is Not a Functional Neurologic Disorder
- Mental health problems raise the odds of cognitive impairment in COVID-19 survivors
- Long COVID clinical evaluation, research and impact on society: a global expert consensus
- Comprehensive MRI assessment reveals subtle brain findings in non-hospitalized post-COVID patients with cognitive impairment
- Neuroimmune pathophysiology of long COVID
- Persistence of spike protein at the skull-meninges-brain axis may contribute to the neurological sequelae of COVID-19
- Alterations in the Glymphatic System and Presence of Small Vessel Disease in Hospitalized and Non-hospitalized COVID Patients: A Study of PSMD Index and DTI-ALPS
- Altered brain tissue microstructure and neurochemical profiles in long COVID and recovered COVID-19 individuals: A multimodal MRI study
- On the existence of stable equilibrium points in space-invariant cellular neural networks
- Accelerating antiviral drug discovery: lessons from COVID-19
- Cerebral gray matter volumes in long-term post-COVID patients are associated with peripheral kynurenine pathway metabolites and the severity of depressive symptoms
- Examining neuroimaging biomarkers, plasma biomarkers and cognitive functions in patients with recovered COVID-19 infection: a multicentre study using 7T MRI
- The APOLLO trial: a proof-of-concept study for vitamin A nasal drops in COVID-19-related postinfectious olfactory dysfunction
- Brain organoids: building higher-order complexity and neural circuitry models
- Blood–brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment
- La Cultura como valor para la Democracia.
- Posthospitalization COVID-19 cognitive deficits at 1 year are global and associated with elevated brain injury markers and gray matter volume reduction
- Overview and Pathophysiology of Long COVID
- Changes in memory function in adults following SARS-CoV-2 infection: Findings from the Covid and Cognition online study
- Microstructural brain abnormalities, fatigue, and cognitive dysfunction after mild COVID-19
- Long COVID: major findings, mechanisms and recommendations
- The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID
- Vascular inflammation in neuropsychiatric long COVID
- The neurobiology of long COVID
- Overnight olfactory enrichment using an odorant diffuser improves memory and modifies the uncinate fasciculus in older adults
- Mechanisms of long COVID and the path toward therapeutics
- A causal link between autoantibodies and neurological symptoms in long COVID
- Intravenous SARS-CoV-2 Spike protein induces neuroinflammation and alpha-Synuclein accumulation in brain regions relevant to Parkinson’s disease
- Long COVID is associated with severe cognitive slowing: a multicentre cross-sectional study
- Biobanking with genetics shapes precision medicine and global health
- Cognitive function and brain structure in COVID-19 survivors: The role of persistent symptoms
- How to understand the overlap of long COVID, chronic fatigue syndrome/myalgic encephalomyelitis, fibromyalgia and irritable bowel syndromes
- Changes in memory and cognition during the SARS-CoV-2 human challenge study
- The Human Microglia Atlas (HuMicA) unravels changes in disease-associated microglia subsets across neurodegenerative conditions
- Long-term effects of SARS-CoV-2 infection on human brain and memory
- Reweighting UK Biobank corrects for pervasive selection bias due to volunteering
- Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
- Neurological Manifestations of SARS-CoV-2
- Blood brain barrier disruption and glutamatergic excitotoxicity in post-acute sequelae of SARS COV-2 infection cognitive impairment: potential biomarkers and a window into pathogenesis
- Evidence of Impaired Neuroimmune System in Post‐COVID Syndrome—A Whole Brain Magnetic Resonance Spectroscopy Study
- A ascensão letal da anticiência
- Neuroinflammation in Post COVID‐19 Sequelae: Neuroinvasion and Neuroimmune Crosstalk
- Multisystem Inflammatory Syndrome in Children and Long COVID: The SARS-CoV-2 Viral Superantigen Hypothesis
- Alzheimer’s therapeutic development: shifting neurodegeneration to neuroregeneration
- Long-COVID cognitive impairments and reproductive hormone deficits in men may stem from GnRH neuronal death
- Mode‐based morphometry: A multiscale approach to mapping human neuroanatomy
- Post-COVID cognitive deficits at one year are global and associated with elevated brain injury markers and grey matter volume reduction: national prospective study
- Neurologic Effects of SARS-CoV-2 Transmitted among Dogs
- The immunology of long COVID
- Oculomotor, vestibular, reaction time, and cognitive tests as objective measures of neural deficits in patients post COVID-19 infection
- Post-COVID-Syndrom – Fokus Fatigue
- SARS-CoV-2 hampers dopamine production in iPSC-derived dopaminergic neurons
- Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants. [europepmc]
- Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. [europepmc]
- Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches. [europepmc]
- Long COVID headache. [europepmc]
- Immunomodulatory Mechanisms of Mesenchymal Stem Cells and Their Potential Clinical Applications. [europepmc]
- Fatigue and cognitive impairment after COVID-19: A prospective multicentre study. [europepmc]
- Long-term neurologic outcomes of COVID-19. [europepmc]
- How COVID-19 shaped mental health: from infection to pandemic effects. [europepmc]
- The neurobiology of long COVID. [europepmc]
- Neuropilin-1 Mediates SARS-CoV-2 Infection of Astrocytes in Brain Organoids, Inducing Inflammation Leading to Dysfunction and Death of Neurons. [europepmc]
- Psychiatric and neurological complications of long COVID. [europepmc]
- Persistent post-COVID-19 smell loss is associated with immune cell infiltration and altered gene expression in olfactory epithelium. [europepmc]
- Innate immune evasion strategies of SARS-CoV-2. [europepmc]
- Long COVID: major findings, mechanisms and recommendations. [europepmc]
- SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice. [europepmc]
- Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC). [europepmc]
- Accelerating antiviral drug discovery: lessons from COVID-19. [europepmc]
- ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature. [europepmc]
- Long COVID prevalence and impact on quality of life 2 years after acute COVID-19. [europepmc]
- Serotonin reduction in post-acute sequelae of viral infection. [europepmc]
- The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID. [europepmc]
- Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. [europepmc]
- Cognition and Memory after Covid-19 in a Large Community Sample. [europepmc]
- Reweighting UK Biobank corrects for pervasive selection bias due to volunteering. [europepmc]
- Mechanisms of long COVID and the path toward therapeutics. [europepmc]
Discussions
Related